secwatch / observer
8-K filed September 8, 2022, 7:59 PM ET ticker CAH CIK 0000721371
leadership confidence high sentiment neutral materiality 0.60

Cardinal Health announces Pharmaceutical Segment CEO change; Crawford out, Weitzman in

CARDINAL HEALTH INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Victor L. Crawford

Chief Executive Officer, Pharmaceutical Segment
CAH · CARDINAL HEALTH INC
Effective
2022-09-19
Filed
September 8, 2022, 7:59 PM ET
On September 8, 2022, Cardinal Health, Inc. (the “Company”) announced that Victor L. Crawford will cease to serve as Chief Executive Officer, Pharmaceutical Segment effective September 19, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Victor L. Crawford departed as Chief Executive Officer, Pharmaceutical Segment at CARDINAL HEALTH INC.

Action
ceased to serve
Role
Chief Executive Officer, Pharmaceutical Segment
Exact text from the filing
On September 8, 2022, Cardinal Health, Inc. (the “Company”) announced that Victor L. Crawford will cease to serve as Chief Executive Officer, Pharmaceutical Segment effective September 19, 2022.
View on SEC.gov

CARDINAL HEALTH INC filing history →

Source: SEC EDGAR
accession 0000721371-22-000101
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.